Ulrike Glaenzel

Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite s

K. Schroer, A. Meissner, G. Camenisch, 2020 .

Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite

K. Schroer, A. Meissner, G. Camenisch, 2020, Drug Metabolism and Disposition.

Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro.

F. Picard, M. Azria, P. J. Swart, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

PIMECROLIMUS: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION IN HEALTHY VOLUNTEERS AFTER A SINGLE ORAL DOSE AND SUPPLEMENTARY INVESTIGATIONS IN VITRO

M. Zollinger, J. Baldeck, A. Schweitzer, 2006, Drug Metabolism and Disposition.

Metabolism and Disposition of Siponimod, a Novel Selective S1P1/S1P5 Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism

K. Schroer, E. Legangneux, A. Meissner, 2018, Drug Metabolism and Disposition.

An integrated assessment of the ADME properties of the CDK4/6 Inhibitor ribociclib utilizing preclinical in vitro, in vivo, and human ADME data

G. Camenisch, Hilmar Schiller, Alexander David James, 2020, Pharmacology research & perspectives.

Pharmacokinetics, Metabolism, and Disposition of Deferasirox in β-Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State

G. Bruin, F. Waldmeier, J. Porter, 2010, Drug Metabolism and Disposition.

Absorption, distribution, metabolism, and excretion of [14C]BYL719 (alpelisib) in healthy male volunteers

L. Trandafir, P. Swart, A. Jakab, 2015, Cancer Chemotherapy and Pharmacology.

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Paul J. Groot-Kormelink, D. Rowlands, H. Danahay, 2021, Journal of medicinal chemistry.

Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers

S. Vaidyanathan, M. Seiberling, F. Waldmeier, 2007, Drug Metabolism and Disposition.

Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro

R. Woessner, G. Camenisch, V. Erpenbeck, 2017, Drug Metabolism and Disposition.